Actively Recruiting
Implementation of Precision Medicine in High-risk Prostate Cancer
Led by Andreas Josefsson · Updated on 2025-09-03
5500
Participants Needed
1
Research Sites
1590 weeks
Total Duration
On this page
Sponsors
A
Andreas Josefsson
Lead Sponsor
U
Umeå University
Collaborating Sponsor
AI-Summary
What this Trial Is About
This project's objective is to initiate a prospective non-interventional clinical study to perform full molecular characterization and subtyping of the primary tumor prostate cancer patients. It will identify, compare, and select biomarkers for treatment response in high-risk/metastatic prostate cancer.
CONDITIONS
Official Title
Implementation of Precision Medicine in High-risk Prostate Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men investigated for suspected prostate cancer
- Signed consent form
You will not qualify if you...
- Difficulty understanding information about the study due to language, cognitive, or other reasons
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Urology, Umeå University Hospital, Region Västerbotten
Umeå, Sweden, 901 85
Actively Recruiting
Research Team
A
Andreas Josefsson, MD, PhD
CONTACT
K
Karin Welen, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here